BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1312272)

  • 1. A novel quasi-viral agent, MaTu, is a two-component system.
    Pastoreková S; Závadová Z; Kostál M; Babusíková O; Závada J
    Virology; 1992 Apr; 187(2):620-6. PubMed ID: 1312272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of MaTu-MN protein in human tumor cultures and in clinical specimens.
    Závada J; Závadová Z; Pastoreková S; Ciampor F; Pastorek J; Zelník V
    Int J Cancer; 1993 May; 54(2):268-74. PubMed ID: 8486430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MaTu--a contaminant or an anti-cancer vaccine?
    Závada J
    Folia Biol (Praha); 1993; 39(4):167-77. PubMed ID: 8187895
    [No Abstract]   [Full Text] [Related]  

  • 4. Sequences of the major antibody binding epitopes of the Indiana serotype of vesicular stomatitis virus.
    Vandepol SB; Lefrancois L; Holland JJ
    Virology; 1986 Jan; 148(2):312-25. PubMed ID: 2417417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An unusual transmissible agent--MaTu.
    Závada J; Závadová Z
    Arch Virol; 1991; 118(3-4):189-97. PubMed ID: 1648895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. II. Monoclonal antibodies of nonneutralizing and cross-reactive epitopes of Indiana and New Jersey serotypes.
    Lefrancois L; Lyles DS
    Virology; 1982 Aug; 121(1):168-74. PubMed ID: 6180551
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoclonal antibodies to the glycoprotein of vesicular stomatitis virus (New Jersey serotype): a method for preliminary mapping of epitopes.
    Bricker BJ; Snyder RM; Fox JW; Volk WA; Wagner RR
    Virology; 1987 Dec; 161(2):533-40. PubMed ID: 2446424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identity of HeLa cell determinants acquired by vesicular stomatitis virus with a tumor antigen.
    Little LM; Zavada J; Der CJ; Huang AS
    Science; 1983 Jun; 220(4601):1069-71. PubMed ID: 6302845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interactionof antiody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies.
    Lefrancios L; Lyles DS
    Virology; 1982 Aug; 121(1):157-67. PubMed ID: 6180550
    [No Abstract]   [Full Text] [Related]  

  • 10. Epitope mapping by deletion mutants and chimeras of two vesicular stomatitis virus glycoprotein genes expressed by a vaccinia virus vector.
    Keil W; Wagner RR
    Virology; 1989 Jun; 170(2):392-407. PubMed ID: 2471352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudotypes of vesicular stomatitis virus with coat antigen of bovine leukaemia virus--VSV (BLV): antigenic surface mosaic and the roles of precipitating antibodies and polycations.
    Závadová Z; Závada J
    Acta Virol; 1980 May; 24(3):166-74. PubMed ID: 6158852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal and polyclonal antibody studies of VSV(hrMMTV) pseudotypes.
    Chan JC; East JL; Bowen JM; Massey R; Schochetman G
    Virology; 1982 Jul; 120(1):54-64. PubMed ID: 6179293
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of glycosylation on the conformational epitopes of the glycoprotein of vesicular stomatitis virus (New Jersey serotype).
    Grigera PR; Mathieu ME; Wagner RR
    Virology; 1991 Jan; 180(1):1-9. PubMed ID: 1701943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic characterization of cell-cultivated astrovirus serotypes and development of astrovirus-specific monoclonal antibodies.
    Herrmann JE; Hudson RW; Perron-Henry DM; Kurtz JB; Blacklow NR
    J Infect Dis; 1988 Jul; 158(1):182-5. PubMed ID: 3134491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A vesicular stomatitis virus (cytomegalovirus) pseudotype and its use in neutralization tests.
    Vonka V; Závadová H; Poláková D
    Intervirology; 1979; 12(1):32-8. PubMed ID: 227814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody against an antigen selectively assembled into vesicular stomatitis virus virions from HeLa cells.
    Poláková K; Závadová Z; Závada J; Russ G
    Int J Cancer; 1984 Jul; 34(1):91-4. PubMed ID: 6086535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes.
    Yewdell JW; Bennink JR; Mackett M; Lefrancois L; Lyles DS; Moss B
    J Exp Med; 1986 Jun; 163(6):1529-38. PubMed ID: 3011949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of MaTu-MX agent as a new strain of lymphocytic choriomeningitis virus (LCMV) and serological indication of horizontal spread of LCMV in human population.
    Reiserová L; Kaluzová M; Kaluz S; Willis AC; Závada J; Závodská E; Závadová Z; Ciampor F; Pastorek J; Pastoreková S
    Virology; 1999 Apr; 257(1):73-83. PubMed ID: 10208922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 28000 molecular weight human cytomegalovirus structural polypeptide studied by means of a specific monoclonal antibody.
    Re MC; Landini MP; Coppolecchia P; Furlini G; La Placa M
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2507-11. PubMed ID: 2997381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudotype particles of vesicular stomatitis virus with surface antigens of bovine leukaemia virus--VSV (BLV) -- as a sensitive probe for detecting antibodies in the sera of spontaneously infected cattle.
    Závada J; Cerný L; Altstein AD; Závadová Z
    Acta Virol; 1978 Mar; 22(2):91-6. PubMed ID: 26209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.